We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Allergan Sues Sandoz Over Glaucoma Drug ANDA

Law360 (April 7, 2009, 12:00 AM EDT) -- Allergan Inc. has sued Novartis AG subsidiary Sandoz Inc. for patent infringement in response to the the generics maker's effort to market its own version of glaucoma treatment Combigan.

The drugmaker filed the suit Tuesday in the U.S. District Court for the Eastern District of Texas after Sandoz filed an abbreviated new drug application with the U.S. Food and Drug Administration in February to market a generic version of Combigan.

In its letter notifying Allergan of the ANDA, Sandoz claimed that Allergan’s existing patents were invalid...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.